Jianke.com, a China-based smart healthcare service platform, has filed for an initial public offering (IPO) on the Hong Kong Stock Exchange, with shares priced between HKD 7.6 and 8.36 per share. The company aims to raise HKD 63.07 million (USD 8.01 million) through the IPO of 23.8 million shares.
Established in 2015 with a focus on chronic disease management, Jianke.com’s core businesses include comprehensive medical services, online retail pharmacy services, customized content, and marketing solutions. As the largest online chronic disease management platform in China by monthly active user count in 2023, the company reported revenues of RMB 2.434 billion in 2023, alongside a net loss of RMB 197 million.- Flcube.com
